Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.4K Sell
2,120
-4,270
-67% -$191K 0.08% 226
2026
Q1
$308K Hold
6,390
0.29% 136
2025
Q4
$310K Sell
6,390
-3,610
-36% -$179K 0.29% 148
2025
Q3
$472K Hold
10,000
0.35% 101
2025
Q2
$483K Hold
10,000
0.28% 128
2025
Q1
$555K Buy
+10,000
New +$541K 0.39% 86

Other funds holding SNY

Corient IA's SNY Position: Q2 2026 in Review

Corient IA reduced its Sanofi (SNY) stake by 67% in Q2 2026, selling an estimated $191K and leaving 2,120 shares worth $90.4K. The position accounts for 0.08% of the portfolio, ranked #226.

Corient IA first reported a position in SNY in Q1 2025 and has held it in 6 quarters since. The position peaked at $555K in Q1 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Corient IA held 2,120 shares of Sanofi worth $90.4K as of Q2 2026.
  • Corient IA sold 4,270 Sanofi shares in Q2 2026, an estimated $191K.
  • Sanofi made up 0.08% of Corient IA's portfolio in Q2 2026, its #226 holding.
  • Corient IA first reported a position in Sanofi in Q1 2025 and has held it in 6 quarters since.
  • Corient IA's Sanofi position peaked at $555K in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.